Retrospective Study
Copyright ©The Author(s) 2020.
World J Hepatol. Dec 27, 2020; 12(12): 1267-1275
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1267
Table 1 Patients’ demographics

EP (n = 65)
DP (n = 120)
P value
Gender, n (%)0.43
Male34 (52.3)70 (58.3)
Female31 (47.7)50 (41.7)
Age (yr)
mean ± SD63.7 ± 10.262.5 ± 11.10.80
Etiology, n (%)
Viral20 (30.7)45 (37.5)0.35
Alcohol26 (40.0)46 (38.3)0.82
Mixed12 (18.4)24 (20.0)0.80
Other7 (10.9)5 (4.2)0.15
Child-Pugh, n (%)
A00N/A
B24 (36.9)36 (30.0)0.41
C41 (63.1)84 (70.0)0.41
Child-Pugh score, mean ± SD11.2 ± 2.911.9 ± 30.52
MELD-Na score, mean ± SD21.4 ± 7.523.6 ± 8.80.28
Table 2 Complications in the early paracentesis group and delayed paracentesis group
Complications, n (%)
EP (n = 65)
DP (n = 120)
P value
SBP10 (15.3)22 (18.3)0.61
HE14 (21.5)54 (45.0)< 0.01a
HRS6 (9.2)26 (21.6)0.03a
UGIB20 (30.5)40 (33.3)0.72
Infections7 (10.7)30 (25.0)0.02a
Table 3 Time of admission, length of stay, in-hospital mortality, and 90-d readmission rate in the early paracentesis group and delayed paracentesis group

EP (n = 65)
DP (n = 120)
P value
Admission, n (%)
Weekday50 (76.9)57 (47.5)< 0.01a
Weekend15 (23.1)63 (52.5)
LOS (d)
mean ± SD6.7 ± 3.812.2 ± 4.50.01a
In-hospital mortality, n (%)4 (6.1)21 (17.5)0.03a
90-d readmission, n (%)11 (18.0)34 (34.3)0.03a
Ascites3 (27.3)16 (47.0)
UGIB5 (45.4)7 (20.5)
HE2 (18.3)10 (29.5)
Other1 (9.0)1 (3.0)
Table 4 The risk of complications developed during hospitalization in the early paracentesis group and delayed paracentesis group
Complication
Cases in the EP group, n (%)
Cases in the DP group, n (%)
OR
95%CI
P value
HE14 (21.5)54 (45)2.981.49-5.95< 0.01a
HRS6 (9.2)26 (21.6)2.711.05-7.000.03a
Infections7 (10.7)30 (25.0)2.761.13-6.700.02a
LOS ≥ 7 d25 (47.6)88 (73.3)3.011.60-5.67< 0.01a
In-hospital mortality4 (6.1)21 (17.5)3.231.05-9.870.03a
90 d readmission11 (18.0)34 (34.3)1.940.90-4.150.08